Bing‐Hui Yang
Impact in
- Hepatology top 0.5%
- Hepatocellular Carcinoma Treatment and Prognosis
- Liver Disease and Transplantation
- Hepatitis C virus research
- Epidemiology top 5%
- Liver Disease Diagnosis and Treatment
- Hepatitis B Virus Studies
Papers in
- Hepatology 21
- Hepatocellular Carcinoma Treatment and Prognosis 20
-
- Liver Disease Diagnosis and Treatment 7
- Hepatitis B Virus Studies 3
- Co-authors
- Zhao–You Tang (8 shared papers)Boheng Zhang (5 shared papers)Xin‐Da Zhou (15 shared papers)Zeng‐Chen Ma (13 shared papers)Zhiying Lin (13 shared papers)Zhao–You Tang (14 shared papers)Ye‐Qin Yu (12 shared papers)Lun–Xiu Qin (4 shared papers)
In The Last Decade
Bing‐Hui Yang
42 papers receiving 2.2k citations
Bing‐Hui Yang's Hit Papers
Peers
Comparison fields: 5 of 97
- Hepatology 1.6k
- Epidemiology 879
- Cancer Research 207
- Oncology 207
- Surgery 236
Countries citing papers authored by Bing‐Hui Yang
This map shows the geographic impact of Bing‐Hui Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bing‐Hui Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bing‐Hui Yang more than expected).
Fields of papers citing papers by Bing‐Hui Yang
This network shows the impact of papers produced by Bing‐Hui Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bing‐Hui Yang. The network helps show where Bing‐Hui Yang may publish in the future.
Co-authors
The 25 scholars most cited alongside Bing‐Hui Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 45 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Randomized controlled trial of screening for hepatocellular carcinoma Hit paper breakdown → | 2004 | 1206 |
| 2 | 2001 | 257 | |
| 3 | 2006 | 134 | |
| 4 | 1989 | 113 | |
| 5 | 1997 | 104 | |
| 6 | 1995 | 46 | |
| 7 | 1993 | 44 | |
| 8 | 2002 | 40 | |
| 9 | 1989 | 37 | |
| 10 | 1997 | 33 | |
| 11 | 2016 | 27 | |
| 12 | 1995 | 26 | |
| 13 | 2002 | 25 | |
| 14 | 1991 | 24 | |
| 15 | 1995 | 22 | |
| 16 | 1995 | 17 | |
| 17 | Changed clinical aspects of primary liver cancer in China during the past 30 years. | 2004 | 15 |
| 18 | 1989 | 15 | |
| 19 | Radiation therapy for the locoregional lymph node metastases from hepatocellular carcinoma, phase I clinical trial. | 2004 | 15 |
| 20 | 2023 | 15 |
About Bing‐Hui Yang
Bing‐Hui Yang is a scholar working on Hepatology, Epidemiology, Radiology, Nuclear Medicine and Imaging, Organic Chemistry and Pulmonary and Respiratory Medicine, having authored 45 papers that have together received 2.3k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (20 papers), Liver Disease Diagnosis and Treatment (7 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (6 papers), Lung Cancer Treatments and Mutations (6 papers), Carbohydrate Chemistry and Synthesis (5 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), Hepatitis B Virus Studies (3 papers) and Synthesis of Organic Compounds (2 papers). The work is most often cited by research in Hepatology (1.6k citations), Epidemiology (879 citations), Cancer Research (207 citations), Oncology (207 citations) and Surgery (236 citations). Bing‐Hui Yang has collaborated with scholars based in China, Japan and Ethiopia. Frequent co-authors include Zhao–You Tang, Boheng Zhang, Xin‐Da Zhou, Zeng‐Chen Ma, Zhiying Lin, Zhao–You Tang, Ye‐Qin Yu, Lun–Xiu Qin, Sheng‐Long Ye and Jia Fan. Their work appears in journals such as Journal of Cancer Research and Clinical Oncology, Cancer, Tetrahedron Letters, Journal of Surgical Oncology and World Journal of Surgery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.